☆ 4.7 Article

Esterified derivatives of DHA and EPA increase bortezomib cytotoxicity in human multiple myeloma cells

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Nutrition & Dietetics

The efficacy of bortezomib in human multiple myeloma cells is enhanced by combination with omega-3 fatty acids DHA and EPA: Timing is essential

Jing Chen et al.

Summary: The study showed cell type-dependent anticancer potential of DHA and EPA. Both compounds induced apoptosis in MM cells via multiple pathways and enhanced bortezomib chemosensitivity by activating NF-kappa B signaling pathway. Timing of concurrent treatment with bortezomib and DHA or EPA is crucial for optimal therapeutic outcomes.

CLINICAL NUTRITION (2021)

Add to Collection

Review Cell Biology

Ferroptosis: molecular mechanisms and health implications

Daolin Tang et al.

Summary: Cell death can be executed through different subroutines, such as ferroptosis which is an iron-dependent form of non-apoptotic cell death. Ferroptosis can occur through two major pathways, driven by redox imbalance and abnormal expression of redox-active enzymes. The process is precisely regulated at multiple levels, with the transcription factor NFE2L2 playing a central role in anti-ferroptotic defense.

CELL RESEARCH (2021)

Add to Collection

Review Oncology

Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death

Melody Caillot et al.

Summary: Multiple myeloma (MM) is a neoplastic disease of plasma cells that is still fatal despite advancements in care, requiring new therapeutic approaches. The accumulation of malignant plasma cells in the bone marrow characterizes MM, and while treatment outcomes have improved, there is a need for new therapies to combat relapse. Plasma cells in MM produce high levels of immunoglobulins leading to intracellular ROS production, and inducing MM cell death through ROS-generating drugs shows promise in overcoming drug resistance.

CANCERS (2021)

Add to Collection

Article Cell Biology

Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation

Jing Chen et al.

Summary: The study demonstrates that pretreating MM cells with DHA/EPA before bortezomib significantly enhances chemosensitivity by decreasing GSH levels and altering metabolism, highlighting the role of GSH degradation in overcoming drug resistance. RNA-seq results suggest the NRF2-ATF3/4-CHAC1 signaling pathway as central in GSH degradation and indicate potential connections to various pathways contributing to the tumor suppressive effect. The findings implicate GSH degradation as a promising therapeutic target in MM and provide new insights into combating bortezomib resistance.

CELLS (2021)

Add to Collection

Article Nutrition & Dietetics

EPA and DHA have selective toxicity for PBMCs from multiple myeloma patients in a partly caspase-dependent manner

Esmaeil Mortaz et al.

CLINICAL NUTRITION (2020)

Add to Collection

Article Allergy

Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI-mediated signaling

Jelle Folkerts et al.

ALLERGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Daratumumab: A Review in Combination Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma

Yvette N. Lamb

DRUGS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Glutathione in Cancer: From Mechanisms to Therapies

Luke Kennedy et al.

BIOMOLECULES (2020)

Add to Collection

Review Oncology

Relapsed refractory multiple myeloma: a comprehensive overview

Abdul Hamid Bazarbachi et al.

LEUKEMIA (2019)

Add to Collection

Review Cell Biology

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

Jing Chen et al.

CELLS (2019)

Add to Collection

Review Oncology

Drug resistance in multiple myeloma

Pawel Robak et al.

CANCER TREATMENT REVIEWS (2018)

Add to Collection

Review Pharmacology & Pharmacy

Modulating ROS to overcome multidrug resistance in cancer

Qingbin Cui et al.

DRUG RESISTANCE UPDATES (2018)

Add to Collection

Article Oncology

CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway

Meng-Shian Chen et al.

ONCOTARGET (2017)

Add to Collection

Letter Oncology

Intracellular glutathione determines bortezomib cytotoxicity in multiple myeloma cells

K. K. Starheim et al.

BLOOD CANCER JOURNAL (2016)

Add to Collection

Article Medicine, General & Internal

Multiple myeloma

Christoph Roellig et al.

LANCET (2015)

Add to Collection

Article Medicine, General & Internal

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

H. M. Lokhorst et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Omega-3 fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells

J. Abdi et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)

Add to Collection

Article Pharmacology & Pharmacy

Effect of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Omeprazole Plasma Pharmacokinetics in Healthy Adults

Rene A. Braeckman et al.

DRUGS IN R&D (2014)

Add to Collection

Review Oncology

Proteasome inhibitors in the treatment of multiple myeloma

Ali McBride et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2013)

Add to Collection

Article Pharmacology & Pharmacy

Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers

Antonio Rusca et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical overview of omacor: A concentrated formulation of omega-3 polyunsaturated fatty acids

Harold Bays

AMERICAN JOURNAL OF CARDIOLOGY (2006)

Add to Collection

Article Nutrition & Dietetics

Distribution, interconversion, and dose response of n-3 fatty acids in humans

Linda M. Arterburn et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)

Add to Collection

Article Biochemical Research Methods

Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib

CR Berkers et al.

NATURE METHODS (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.